Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Trial of Immune Globulin in Infant Botulism
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is in the following collections:

Pediatric Neurology Briefs: Volume 20, Issue 02

Trial of Immune Globulin in Infant Botulism Open Access (recommended)

Descriptions

Resource type(s)
Article
Keyword
Infant Botulism
Werdnig Hoffman
Human Botulism Immune Globulin Intravenous
Rights
Attribution 4.0 International

Creator
Millichap, J. Gordon
Abstract
A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin) was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.
Publisher
DigitalHub. Galter Health Sciences Library
Pediatric Neurology Briefs Publishers
Date Created
2006
Original Identifier
PNB-20-13
Language
English
Subject: MESH
Infant
Child Development
Neurosurgery
Nervous System Diseases
Child
Pediatrics
Neurology
Brain Diseases
DOI
10.15844/pedneurbriefs-20-2-5

File Details

File Properties
Mime type: application/pdf
File size: 1241.7 kB